LBO — WEIRTON MEDICAL CENTER
IRR: 17.7% | MOIC: 2.26x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.7%
IRR
2.26x
MOIC
$176.1M
Entry EV
$276.6M
Exit EV
$90.6M
Equity Invested
Sources & Uses
S&UTotal · $176.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $68.4M | 38.8% | |
| Sub Debt | $17.1M | 9.7% | |
| Equity | $90.6M | 51.5% | |
| Enterprise Value | $170.9M | 97.1% | |
| Transaction Fees | $5.1M | 2.9% | |
| Total Uses | $176.1M | 100.0% |
Interpretation
INTAt 2.26x MOIC and 17.7% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $26.3M |
| Exit Ev | $276.6M |
| Net Debt At Exit | $72.1M |
| Equity At Exit | $204.5M |
| Equity Invested | $90.6M |
| Total Value Created | $113.9M |
| Value From Growth | $97.1M |
| Value From Multiple | $8.5M |
| Value From Deleveraging | $13.4M |